Hepatitis C eradication improves cognitive function in patients with or without cirrhosis: A prospective real-life study.
Luis Ibáñez-SamaniegoMarta Rapado-CastroLucia CabreroCristina NavarreteSeila García-MulasAdriana AhumadaLaura MarquezMaria Dolores PérezDiego RinconRafael BañaresRita Garcia-MartinezPublished in: European journal of neurology (2021)
Viral eradication decreases the prevalence of cognitive impairment and improves functioning and HRQoL. Patients with lower brain reserve (older patients) and baseline cognitive impairment may benefit the most. Identification and treatment of HCV patients through screening programs may reduce the burden of cognitive disturbances beyond the prevention of liver disease progression.
Keyphrases
- cognitive impairment
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- helicobacter pylori infection
- risk factors
- hepatitis c virus
- public health
- sars cov
- prognostic factors
- resting state
- multiple sclerosis
- combination therapy
- human immunodeficiency virus
- brain injury
- patient reported outcomes
- functional connectivity
- blood brain barrier
- bioinformatics analysis